A proposal announced by President Trump last month was to send older Americans $200 discount cards to offset prescription costs. It’s not going to happen before the election, and maybe not ever.
After months of caving to pressures from the White House, Commissioner Stephen Hahn and a band of agency scientists have eked out a few victories.
The reversal came just hours after the federal government threatened the state, calling the prohibition on the tests “illegal.”
The order would have mandated that both passengers and employees wear face coverings on planes, trains, buses and subways and in airports, stations and depots.
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
Dr. Rick Bright, who said he was demoted at the health department for blowing the whistle on a politicized coronavirus response, remains concerned about White House interference.
Documents and interviews show how senior officials sought to play down the risks of sending children back to the classroom, alarming public health experts.
A managing editor of the right-wing website RedState appeared to attack Dr. Anthony S. Fauci and spread misinformation about the coronavirus pandemic while working for Dr. Fauci’s agency.
The agency now says anyone exposed to an infected person for more than 15 minutes needs a test. An earlier guideline saying it might not be necessary had shocked public health experts.
Emails from a former top Trump health official and his science adviser show how the two refused to accept Centers for Disease Control and Prevention science and sought to silence the agency.
A controversial guideline saying people without Covid-19 symptoms didn’t need to get tested for the virus came from H.H.S. officials and skipped the C.D.C.’s scientific review process.
A public scolding of the C.D.C. chief was only the latest but perhaps the starkest instance when the president has rejected not just the policy advice of his public health officials but the facts and information that they provided.
Michael R. Caputo, the assistant secretary of health for public affairs, and his science adviser will be leaving the Department of Health and Human Services after both criticized the C.D.C.
Michael R. Caputo, the head of communications at the Department of Health and Human Services, apologized to the health secretary and his staff and is considering a medical leave.
If the president’s allies are talking about the moment “shooting will begin” and “martial law,” it’s not by accident.
Michael R. Caputo told a Facebook audience without evidence that left-wing hit squads were being trained for insurrection and accused C.D.C. scientists of “sedition.”
Michael Caputo, the assistant secretary of health for public affairs, told a Facebook audience without evidence that left-wing hit squads were being trained for insurrection, and he accused C.D.C. scientists of “sedition.”
The order expands on a presidential promise by trying to reduce the prices Medicare pays for prescription drugs, but experts said it was unclear whether the White House could carry out the directive.
New details of how the president has demanded faster action from health agencies help explain the intensifying concern that he could demand pre-Election Day approval of a vaccine.
A yearlong investigation into Seema Verma, the head of the Centers for Medicare and Medicaid Services, showed the cozy relations that fuel the nation’s capital at taxpayer expense.
The buzzy idea is impractical, critics said. And there isn’t yet real-world data to show it will work.
Six months into the pandemic and with no coherent national testing strategy, the Trump administration is encouraging private development of an array of faster and cheaper techniques.
The agency’s chief spokeswoman, Emily Miller, was removed from her position just 11 days into the job. And the contract was terminated of a consultant who had advised the F.D.A. chief to correct misleading claims about plasma’s benefits.
The Centers for Disease Control and Prevention abruptly changed its recommendations, saying people without Covid-19 symptoms should not get tested.
As summer draws to a close, four new developments in the treatment and understanding of the coronavirus have arisen in the United States and abroad.
The Department of Health and Human Services told hospitals in April that reporting to the vendor, TeleTracking Technologies, was a “prerequisite to payment.”
Pharmacists may now vaccinate young children under a new federal emergency rule aimed at helping families who missed well-child visits during the pandemic.
A new advisory board, appointed by the Trump administration, recommended that the health secretary reject funding for virtually every fetal tissue research project it considered.
The decision arrived a day before a Trump administration rule narrowing the legal definition of sex discrimination was set to take effect.
The goal of the initiative is admirable: getting a coronavirus vaccine out to Americans and saving lives as soon as possible. It is not, however, without its problems.
A private technology company that gathers data for a coronavirus database said a nondisclosure agreement with the Trump administration blocks it from discussing its $10.2 million contract.
For the first time during the pandemic, the United States saw a downward trend in the number of coronavirus tests conducted each day.
An administration shift is putting a burden on hospitals and undercutting the integrity of data on the pandemic, current and former members of a federal advisory panel said.
Many medical experts — including members of his own staff — worry about whether Dr. Hahn has the fortitude and political savvy to protect the scientific integrity of the F.D.A. from Mr. Trump.
Inovio, a Pennsylvania biotech company, has spent years claiming to be on the cusp of important vaccines. It has never brought one to market.
Consumers are probably entitled to millions of dollars in rebates under Obamacare rules that cap companies’ profits.
Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have shown whether the therapy worked.
The trip by Alex M. Azar II, a rare high-level U.S. visit, is being billed as an opportunity to highlight Taiwan’s success in battling the coronavirus pandemic.
Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have showed whether the therapy worked.
Operation Warp Speed has moved along at a rapid clip. But some people involved in the approval process fear pressure to deliver an October surprise for President Trump.
She and other top health officials in the Trump administration warn states of a deepening spread of the coronavirus, in both rural and urban areas.
The federal government must work to ensure adequate supply of the coronavirus drug — and distribute it evenly and transparently.
The agency’s statement followed earlier criticism from President Trump that its guidelines for reopening were too “tough.”